Elsevier’s Clinical Pharmacology Now Accessible Through Elsevier Infobutton
Elsevier Infobutton now links from EHRs to key content in Clinical Pharmacology
Tampa, FL, November 28, 2012 – Elsevier’s Gold Standard, a leading drug information provider, announced today that its Clinical Pharmacology drug reference solution will be accessible through the recently launched Elsevier Infobutton, a one-touch service that links from an EHR (electronic health record) to evidence-based content in Elsevier electronic information solutions. Institutions with an EHR can license and then link to Elsevier’s comprehensive drug reference content in Clinical Pharmacology through clinical terms in the patient record.
The Elsevier Infobutton helps providers achieve EHR certification for Stage 2 Meaningful Use by supporting these HL7 (Health Level Seven International) Infobutton standard use cases:
- Context--sensitive links that reference information to support clinical decision-making
- Links to patient-specific education resources
“The Elsevier Infobutton demonstrates real value at the point-of-care by simplifying access to clinical decision support information and patient education materials that improve care and patient outcomes,” said Marianne Messer, President, Elsevier’s Gold Standard. “Our goal continues to focus on providing solutions that elevate the standard of care through easily-accessible, user-friendly, evidence-based drug information.”
The Elsevier Infobutton is offered free-of-charge to customers with an EHR who also license other Elsevier electronic information products, including Clinical Pharmacology, Mosby’s Nursing Consult and Mosby’s Skills.
For more information about Elsevier Infobutton please visit www.elsinfobutton.com.
# # #
About Elsevier’s Gold Standard
Based in Tampa, FL, Elsevier’s Gold Standard uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Elsevier’s Gold Standard solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Elsevier’s Gold Standard, visit www.goldstandard.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 33,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact
Director, Corporate Relations
+1 212 633 3164